PlainRecalls
FDA Drug Moderate Class II Terminated

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.

Reported: December 14, 2022 Initiated: December 5, 2022 #D-0077-2023

Product Description

Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.

Reason for Recall

Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
9 boxes
Distribution
Product was distributed to two different customers in MI.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.. Recalled by RemedyRepack Inc.. Units affected: 9 boxes.
Why was this product recalled?
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 14, 2022. Severity: Moderate. Recall number: D-0077-2023.